Monthly News Roundup - October 2023

FDA Clears Loqtorzi as First Treatment for Nasopharyngeal Carcinoma (NPC)
In October, the U.S. Food and Drug Administration (FDA) approved Coherus BioSciences’ Loqtorzi (toripalimab-tpzi) to treat adult patients with metastatic or recurrent...